MAPK8 and chronic myelogenous leukemia, BCR-ABL1 positive: In osteoblast cells CML-collagen-induced apoptosis, and therefore impaired bone formation, was reduced by p38 MAPK (45%) or JNK (59%) inhibitors, and the effect was additive as treatment with both kinase inhibitors caused a 90% reduction in cell apoptosis [21].